![Zohar Koren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Zohar Koren
Directeur Général chez
SciCann Therapeutics, Inc.
Profil
Zohar Koren is the founder of Cannabics, Inc. (2012).
Dr. Koren is the founder of CNBX Pharmaceuticals, Inc. (2014).
Dr. Koren is the founder of Xinteza API Ltd. (2019) and holds the title of Chief Technology Officer.
Dr. Koren is also the founder of SciCann Therapeutics, Inc. Dr. Koren is the Chief Executive Officer of OncoDecipher Ltd. since 2024.
Formerly, Dr. Koren served as Director at Alterola Biotech, Inc. (California).
Education includes an undergraduate degree from The Hebrew University of Jerusalem, a graduate degree, and a doctorate from the University of Haifa.
Postes actifs de Zohar Koren
| Sociétés | Poste | Début |
|---|---|---|
SciCann Therapeutics, Inc.
 SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Directeur Général | - |
Xinteza API Ltd.
 Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Fondateur | 17/03/2019 |
Oncodecipher
 Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Directeur Général | 01/02/2024 |
Anciens postes connus de Zohar Koren
| Sociétés | Poste | Fin |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Fondateur | 23/01/2015 |
| ALTEROLA BIOTECH, INC. | Directeur/Membre du Conseil | - |
Cannabics, Inc.
 Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Fondateur | - |
Formation de Zohar Koren
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
CNBX Pharmaceuticals, Inc.
 CNBX Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery, development and commercialization of novel cannabinoid-based products and innovative technologies for the treatment of cancer | Health Technology |
Alterola Biotech, Inc. (California)
 Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums | Process Industries |
Cannabics, Inc.
Cannabics, Inc. Financial ConglomeratesFinance Provides cannabinoid-based therapy through its subsidiary | Finance |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Haifa
 University of Haifa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xinteza API Ltd.
Xinteza API Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
SciCann Therapeutics, Inc.
SciCann Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Oncodecipher
Oncodecipher Packaged SoftwareTechnology Services Develops a AI powered platform designed to detect and analyze novel genetic variations as biomarkers for therapies | Technology Services |
